Angela Messmer-Blust

Angela Messmer-Blust serves as Associate Professor at UMass Chan Medical School with primary appointment in the RNA Therapeutics Institute within the T.H. Chan School of Medicine, supplemented by roles in the Morningside Graduate School of Biomedical Sciences' Interdisciplinary Graduate Program and RNA Therapeutics and Biology Program. Her research bridges molecular mechanisms with vascular physiology, particularly focusing on transcriptional regulation in endothelial cells.

• BS in Biology from University of Toledo
• PhD in Biology from University of Toledo

Dr. Messmer-Blust's research centers on two interconnected domains: transcriptional enhancer factors (particularly RTEF-1) in cardiovascular function and interferon-induced GTPases in cellular regulation. Her laboratory investigates how RTEF-1 governs endothelial cell connections, microvascular relaxation, angiogenesis, and metabolic processes through regulation of insulin-like growth factor binding proteins. Simultaneously, her work on mGBP-2 reveals how this interferon-induced GTPase modulates cell adhesion, migration, and inflammatory responses by inhibiting Rac activation and NF-kappaB signaling pathways. These research streams converge on understanding molecular mechanisms underlying vascular integrity, inflammation, and tissue repair.

Analysis of her publication timeline (2009-2015) reveals consistent contributions to endothelial cell biology, with particular emphasis on transcriptional regulation of vascular function. Her work demonstrates how RTEF-1 intersects with hypoxia signaling, metabolic regulation, and vascular development, while her research on mGBP-2 establishes critical connections between immune signaling and cytoskeletal dynamics. The recurring themes of transcriptional control and cellular signaling across both research areas highlight her integrative approach to vascular molecular biology.

While specific awards aren't detailed in available records, her publication impact is evident through significant citation metrics - particularly her Molecular Biology of the Cell paper on mGBP-2 (22 citations) and Journal of Biological Chemistry work on RTEF-1 (16 citations). These metrics indicate substantial influence in cardiovascular and cell biology research communities.

As faculty member, Dr. Messmer-Blust contributes to graduate education through multiple programs at UMass Chan Medical School. Her research likely involves collaborative networks given the multi-institutional authorship patterns in her publications, though specific grant details aren't provided in available materials. Her work appears strategically positioned at the intersection of RNA therapeutics and cardiovascular biology within the institutional research ecosystem.

Her laboratory operations are centered within the RNA Therapeutics Institute, leveraging institutional strengths in RNA-based research while applying these approaches to cardiovascular questions. The integration of transcriptional regulation studies with vascular physiology suggests active participation in cross-departmental research initiatives focused on molecular mechanisms of heart and vascular diseases.